{'fraction_non_alphanumeric': 0.03417533432392273, 'fraction_numerical': 0.022288261515601784, 'mean_word_length': 4.912280701754386, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Isolation and antitumor activity of cyclic hexapeptides isolated from Rubiae radix.

The details of the isolation and antitumor activity of cyclic hexapeptides (RA-VII, RA-V, RA-IV and RA-III) isolated from Rubia cordifolia are reported. Studies on a spectrum of experimental tumors in mice revealed that the peptides exhibited significant activity against leukemias and ascites tumors, P-388, L1210, B-16 melanoma and solid tumors, colon 38, Lewis lung carcinoma and Ehrlich carcinoma. RA-V had an especially potent effect on MM2 mammary carcinoma in mice. The effective dose range of RA-IV against P-388 leukemia was different from those of the other cyclic hexapeptides.